The removal of tissue or cells for medical analysis from a patient’s body is called a biopsy. Biopsy is mainly done to see if the patient is infected by the deadly disease cancer and if there is a chance that a patient is suspected to have cancer, a biopsy is utilized to separate tissue tests for finding and assurance of growth. The system is performed by interventional radiologists to distinguish disease and the end-clients of this market are diagnostic centers, hospitals and other medical clinics. There are more than 100 sorts of cancers and the greater part of them is classified by the organ, for example, colon disease and melanoma. There are different sorts of biopsy utilized as a part of conclusion of diseases, for example, skin biopsy, incision & excision biopsy,shave biopsy, fine needle aspiration, center needle biopsy and vacuum-assisted biopsy. Vacuum assisted biopsy strategy is the quickest developing biopsy technique and this is most important amongst the most critical indicative techniques for the analysis of cancer disease.
How Big is The Global Biopsy Devices Market?
The Global Biopsy Devices Market is expected to exceed more than US$ 3 billion by 2028 at a CAGR of 6.5%.
The major driving factors of Global Biopsy Devices Market are as follows:
The restraining factors of Global Biopsy Devices Market are as follows:
The Global Biopsy Devices Market is segmented on the lines of its product, application, end user and regional. Based on product segmentation it covers guidance system, needles, guns, reagents and kits, others. Based on application segmentation it covers scientific research, medical diagnostics. Based on end user segmentation it covers hospitals, specialized oncology centers, diagnostic centers, research institutes. The Global Biopsy Devices Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for Global Biopsy Devices Market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Global Biopsy Devices Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Global Biopsy Devices Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Becton, Dickinson and Company , Argon Medical Inc., B. Braun Melsungen AG, Boston Scientific Inc., .C. R. Bard, Inc., Hologic, Inc., Cook Medical, INRAD Inc., Devicor Medical Products Inc., PLANMED OY. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Biopsy Devices Market has been segmented as below:
By Product Analysis:
By Application Analysis:
By End Users Analysis:
By Regional Analysis:
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Biopsy Devices Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Biopsy Devices Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
Orthopaedic Prosthetics Market
Orthopedic Braces and Supports Market
Orthopedic Clinics Braces and Support Casting and Splints market
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Parent / Associated Market Overview
3. Global Biopsy Device Analysis Scenario
3.1. Pricing Analysis
3.1.1. Pricing Assumptions
3.1.2. Price Projections Per Region
3.2. Market Size (US$ Mn) and Forecast
3.2.1. Market Size and Y-o-Y Growth
3.2.2. Absolute $ Opportunity
3.3. Market Overview
3.3.1. Value Chain
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors – Relevance and Impact
4.6. Global Incidence of Cancer
4.7. Global Trends
5. Global Biopsy Device Analysis and Forecasts, By Product
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type
5.3. Y-o-Y Growth Projections By Product Type
5.4. Market Value and Volume Forecast By Product, 2016–2026
5.4.1. Guidance System
5.4.1.1. Stereotactic X-Ray Guided Biopsy
5.4.1.2. Ultrasound Guided Biopsy
5.4.1.3. MRI Guided Biopsy
5.4.2. Needles
5.4.2.1. Core Needle
5.4.2.2. Fine Aspiration Needles
5.4.3. Guns
5.4.4. Reagents and Kits
5.4.5. Others (Brushes, Curettes and Punches etc.)
5.5. Market Attractiveness By Product
6. Global Biopsy Device Analysis and Forecasts, By Application
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Application
6.3. Y-o-Y Growth Projections By Application
6.4. Market Value Forecast By Application, 2016–2026
6.4.1. Scientific Research
6.4.2. Medical Diagnostics
6.5. Market Attractiveness By Application
7. Global Biopsy Device Analysis and Forecasts, By End Users
7.1. Introduction
7.2. Basis Point Share (BPS) Analysis By End Users
7.3. Y-o-Y Growth Projections By End Users
7.4. Market Value Forecast By End Users, 2016–2026
7.4.1. Hospitals
7.4.2. Specialized Oncology Centers
7.4.3. Diagnostic Centers
7.4.4. Research Institutes
7.5. Market Attractiveness By End Users
8. Global Biopsy Device Analysis and Forecasts, By Region
8.1. Basis Point Share (BPS) Analysis By Region
8.2. Y-o-Y Growth Projections By Region
8.3. Market Value Forecast By Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. APEJ
8.3.6. Japan
8.3.7. MEA
8.4. Market Attractiveness By Region
9. North America Biopsy Device Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2. Market Value and Volume Forecast By Product, 2016–2026
9.2.1. Guidance System
9.2.1.1. Stereotactic X-Ray Guided Biopsy
9.2.1.2. Ultrasound Guided Biopsy
9.2.1.3. MRI Guided Biopsy
9.2.2. Needles
9.2.2.1. Core Needle
9.2.2.2. Fine Aspiration Needles
9.2.3. Guns
9.2.4. Reagents and Kits
9.2.5. Others (Brushes, Curettes and Punches etc.)
9.3. Market Value Forecast By Application, 2016–2026
9.3.1. Scientific Research
9.3.2. Medical Diagnostics
9.4. Market Value Forecast By End Users, 2016–2026
9.4.1. Hospitals
9.4.2. Specialized Oncology Centers
9.4.3. Diagnostic Centers
9.4.4. Research Institutes
9.5. Market Value Forecast By Country, 2016–2026
9.5.1. US
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Product
9.6.2. By Application
9.6.3. By End Users
9.6.4. By Country
10. Latin America Biopsy Device Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2.Market Value and Volume Forecast By Product, 2016–2026
10.2.1. Guidance System
10.2.1.1. Stereotactic X-Ray Guided Biopsy
10.2.1.2. Ultrasound Guided Biopsy
10.2.1.3. MRI Guided Biopsy
10.2.2. Needles
10.2.2.1. Core Needle
10.2.2.2. Fine Aspiration Needles
10.2.3. Guns
10.2.4. Reagents and Kits
10.2.5. Others (Brushes, Curettes and Punches etc.)
10.3.Market Value Forecast By Application, 2016–2026
10.3.1. Scientific Research
10.3.2. Medical Diagnostics
10.4.Market Value Forecast By End Users, 2016–2026
10.4.1. Hospitals
10.4.2. Specialized Oncology Centers
10.4.3. Diagnostic Centers
10.4.4. Research Institutes
10.5.Market Value Forecast By Country, 2016–2026
10.5.1. Argentina
10.5.2. Brazil
10.5.3. Mexico
10.5.4. Rest of Latin America
10.6.Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End Users
10.6.4. By Country
11. Western Europe Biopsy Device Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Key Regulations
11.2.Market Value and Volume Forecast By Product, 2016–2026
11.2.1. Guidance System
11.2.1.1. Stereotactic X-Ray Guided Biopsy
11.2.1.2. Ultrasound Guided Biopsy
11.2.1.3. MRI Guided Biopsy
11.2.2. Needles
11.2.2.1. Core Needle
11.2.2.2. Fine Aspiration Needles
11.2.3. Guns
11.2.4. Reagents and Kits
11.2.5. Others (Brushes, Curettes and Punches etc.)
11.3.Market Value Forecast By Application, 2016–2026
11.3.1. Scientific Research
11.3.2. Medical Diagnostics
11.4.Market Value Forecast By End Users, 2016–2026
11.4.1. Hospitals
11.4.2. Specialized Oncology Centers
11.4.3. Diagnostic Centers
11.4.4. Research Institutes
11.5.Market Value Forecast By Country, 2016–2026
11.5.1. UK
11.5.2. France
11.5.3. Germany
11.5.4. Italy
11.5.5. Spain
11.5.6. Nordic
11.5.7. Benelux
11.5.8. Rest of Western Europe
11.6.Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End Users
11.6.4. By Country
12. Eastern Europe Biopsy Device Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.1.3. Key Regulations
12.2.Market Value and Volume Forecast By Product, 2016–2026
12.2.1. Guidance System
12.2.1.1. Stereotactic X-Ray Guided Biopsy
12.2.1.2. Ultrasound Guided Biopsy
12.2.1.3. MRI Guided Biopsy
12.2.2. Needles
12.2.2.1. Core Needle
12.2.2.2. Fine Aspiration Needles
12.2.3. Guns
12.2.4. Reagents and Kits
12.2.5. Others (Brushes, Curettes and Punches etc.)
12.3.Market Value Forecast By Application, 2016–2026
12.3.1. Scientific Research
12.3.2. Medical Diagnostics
12.4.Market Value Forecast By End Users, 2016–2026
12.4.1. Hospitals
12.4.2. Specialized Oncology Centers
12.4.3. Diagnostic Centers
12.4.4. Research Institutes
12.5.Market Value Forecast By Country, 2016–2026
12.5.1. Russia
12.5.2. Poland
12.5.3. Rest of Eastern Europe
12.6.Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End Users
12.6.4. By Country
13. APEJ Biopsy Device Analysis and Forecast
13.1.Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.1.3. Key Regulations
13.2.Market Value and Volume Forecast By Product, 2016–2026
13.2.1. Guidance System
13.2.1.1. Stereotactic X-Ray Guided Biopsy
13.2.1.2. Ultrasound Guided Biopsy
13.2.1.3. MRI Guided Biopsy
13.2.2. Needles
13.2.2.1. Core Needle
13.2.2.2. Fine Aspiration Needles
13.2.3. Guns
13.2.4. Reagents and Kits
13.2.5. Others (Brushes, Curettes and Punches etc.)
13.3.Market Value Forecast By Application, 2016–2026
13.3.1. Scientific Research
13.3.2. Medical Diagnostics
13.4.Market Value Forecast By End Users, 2016–2026
13.4.1. Hospitals
13.4.2. Specialized Oncology Centers
13.4.3. Diagnostic Centers
13.4.4. Research Institutes
13.5.Market Value Forecast By Country, 2016–2026
13.5.1. China
13.5.2. India
13.5.3. Australia & New Zealand
13.5.4. ASEAN
13.5.5. Rest of APEJ
13.6.Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End Users
13.6.4. By Country
14. Japan Biopsy Device Analysis and Forecast
14.1.Introduction
14.1.1. Basis Point Share (BPS) Analysis By Country
14.1.2. Y-o-Y Growth Projections By Country
14.1.3. Key Regulations
14.2.Market Value and Volume Forecast By Product, 2016–2026
14.2.1. Guidance System
14.2.1.1. Stereotactic X-Ray Guided Biopsy
14.2.1.2. Ultrasound Guided Biopsy
14.2.1.3. MRI Guided Biopsy
14.2.2. Needles
14.2.2.1. Core Needle
14.2.2.2. Fine Aspiration Needles
14.2.3. Guns
14.2.4. Reagents and Kits
14.2.5. Others (Brushes, Curettes and Punches etc.)
14.3.Market Value Forecast By Application, 2016–2026
14.3.1. Scientific Research
14.3.2. Medical Diagnostics
14.4.Market Value Forecast By End Users, 2016–2026
14.4.1. Hospitals
14.4.2. Specialized Oncology Centers
14.4.3. Diagnostic Centers
14.4.4. Research Institutes
14.5.Market Attractiveness Analysis
14.5.1. By Product
14.5.2. By Application
14.5.3. By End Users
15. MEA Biopsy Device Analysis and Forecast
15.1.Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.1.3. Key Regulations
15.2.Market Value and Volume Forecast By Product, 2016–2026
15.2.1. Guidance System
15.2.1.1. Stereotactic X-Ray Guided Biopsy
15.2.1.2. Ultrasound Guided Biopsy
15.2.1.3. MRI Guided Biopsy
15.2.2. Needles
15.2.2.1. Core Needle
15.2.2.2. Fine Aspiration Needles
15.2.3. Guns
15.2.4. Reagents and Kits
15.2.5. Others (Brushes, Curettes and Punches etc.)
15.3.Market Value Forecast By Application, 2016–2026
15.3.1. Scientific Research
15.3.2. Medical Diagnostics
15.4.Market Value Forecast By End Users, 2016–2026
15.4.1. Hospitals
15.4.2. Specialized Oncology Centers
15.4.3. Diagnostic Centers
15.4.4. Research Institutes
15.5.Market Value Forecast By Country, 2016–2026
15.5.1. GCC Countries
15.5.2. South Africa
15.5.3. North Africa
15.5.4. Rest of MEA
15.6.Market Attractiveness Analysis
15.6.1. By Product
15.6.2. By Application
15.6.3. By End Users
15.6.4. By Country
16. Competition Landscape
16.1. Competition Dashboard
16.2. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
16.2.1. Becton, Dickinson and Company
16.2.2. Argon Medical Inc.
16.2.3. B. Braun Melsungen AG
16.2.4. Boston Scientific Inc.
16.2.5. C. R. Bard, Inc.
16.2.6. Hologic, Inc.
16.2.7. Cook Medical
16.2.8. INRAD Inc.
16.2.9. Devicor Medical Products Inc.
16.2.10. PLANMED OY
The Global Biopsy Devices Market has been segmented as below:
By Product Analysis:
By Application Analysis:
By End Users Analysis:
By Regional Analysis:
SUBSCRIBE TO OUR NEWSLETTERS
